Clinical Trial Update: GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of gemcitabine plus nab-paclitaxel and losartan followed by stereotactic radiotherapy for locally advanced pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)
• Cozaar (Losartan) (Losartan)
• Gemzar (gemcitabine) (gemcitabine)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Pancreatic Cancer | Phase 2 | Status: WITHDRAWN